Sun Pharmaceutical Faces Performance Challenges Amid Rising Investor Participation
Sun Pharmaceutical Industries Ltd experienced significant trading activity today, with nearly 960,000 shares exchanged and a total value of around Rs 15,191.16 lakhs. Despite recent performance challenges, including consecutive losses, the stock remains a key player in the Pharmaceuticals & Biotechnology sector, attracting increased investor participation.
Sun Pharmaceutical Industries Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has been notably active in the market today. The stock, trading under the symbol SUNPHARMA, recorded a total traded volume of 959,971 shares, with a total traded value of approximately Rs 15,191.16 lakhs. Opening at Rs 1,593.1, the stock reached a day high of Rs 1,600.0 before settling at a last traded price of Rs 1,577.2. This marks a decline of 1.33% for the day, underperforming the sector, which saw a decrease of 0.87%. Sun Pharma has faced consecutive losses over the past two days, accumulating a total decline of 4.63% during this period.
The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a challenging performance trend. Notably, there has been a rise in investor participation, with delivery volume on August 26 reaching 27.89 lakhs, an increase of 87.65% compared to the 5-day average.
With a market capitalization of Rs 3,84,002.00 crore, Sun Pharmaceutical Industries continues to be a significant entity in its industry, despite recent performance challenges. Overall, the stock's activity today reflects ongoing market dynamics and investor engagement.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
